Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population

International Journal of Food Sciences and Nutrition

Volumn 62, Issue 4, 2011, Pages 423-430

  Sakai, Takafumi ^a   Makino, Hiroshi ^a   Ishikawa, Eiji ^a   Oishi, Kenji ^a   Kushiro, Akira ^a  

^a Yakult Honsha European Research Center for Microbiology   (Belgium)

Author keywords

Bristol Stool Form Scale; constipation; hard or lumpy stools; Probiotics; stool consistency

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; FECES; FEMALE; FERMENTATION; FOOD CONTROL; HUMAN; LACTOBACILLUS CASEI; MALE; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; TREATMENT OUTCOME;

ADULT; CONSTIPATION; CULTURED MILK PRODUCTS; FECES; FEMALE; FERMENTATION; FOOD MICROBIOLOGY; HUMANS; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; PROBIOTICS; REFERENCE VALUES; TREATMENT OUTCOME; YOUNG ADULT;

LACTOBACILLUS CASEI;

EID: 79955068913     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2010.542408     Document Type: Article

References (26)

1. Bassotti G, Bellini M, Pucciani F, Bocchini R, Bove A, Alduini P, Battaglia E, Bruzzi P, Italian Constipation Study Group. 2004. An extended assessment of bowel habits in a general population. World J Gastroenterol 10:713-716. (Pubitemid 38351542)
2. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. 2008. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358:2344-2354. (Pubitemid 351749158)
3. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, et al. 2004. PASSCLAIM-gut health and immunity. Eur J Nutr 43(Suppl 2):II118-II173.
4. Degen LP, Phillips SF. 1996. How well does stool form reflect colonic transit? Gut 39:109-113. (Pubitemid 26239116)
5. De Paula JA, Carmuega E,Weill R. 2008. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam 38:16-25.
6. Ferrazzi S, Thompson GW, Irvine EJ, Pare P, Rance L. 2002. Diagnosis of constipation in family practice. Can J Gastroenterol 16:159-164. (Pubitemid 34546289)
7. Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. 2004. Prevalence of constipation: Agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 159:520-526. (Pubitemid 38280299)
8. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH. 2007. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 26:475-486. (Pubitemid 47063138)
9. Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. 2009. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: A randomised, double-blind, parallel, controlled study. Br J Nutr 22:1-9.
10. Heaton KW, Ghosh S, Braddon FEM. 1991. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 32:73-79.
11. Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, et al. 2005. Tegaserod for treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 100:362-372. (Pubitemid 40314521)
12. Kikuchi H, Tajima T. 1992. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric 60:139-146.
13. Koch GG, Gansky SA. 1996. Statistical considerations for multiplicity in confirmatory protocols. Drug Inform J 30: 523-533.
14. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. 2003. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in subjects with chronic constipation. Can J Gastroenterol 17:655-659. (Pubitemid 37536846)
15. Lewis SJ, Heaton KW. 1997. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920-924. (Pubitemid 27382038)
16. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 2006. Functional bowel disorders. Gastroenterology 130:1480-1491.
17. Matsumoto K, Takada T, Shimizu K, Kado Y, Kawakami K, Makino I, Yamaoka Y, Hirano K, Nishimura A, Kajimoto O, Nomoto K. 2006. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: A randomized placebo-controlled cross-over study. Bioscince Microflora 25:39-48.
18. McCrea GL, Miaskowski C, Stotts NA, Macera L, Hart SA, Varma MG. 2008. Review article: Self-report measures to evaluate constipation. Aliment Pharmacol Ther 27:638-648. (Pubitemid 351406303)
19. O'Donnell LJD, Virjee J, Heaton KW. 1990. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit time. Br Med J 300:439-440. (Pubitemid 20069266)
20. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. 2008. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 8:5.
21. Probert CJS, Emmett PM, HeatonKW. 1993. Intestinal transit time in the population calculated from self made observations of defecation. J Epidemiol Community Health 47:331-333. (Pubitemid 23256212)
22. Probert CJS, Emmett PM, Heaton KW. 1995. Some determinants of whole-gut transit time: a population based study. Q JMed 88: 311-315.
23. Quigley EMM, Vandeplassche L, Kerstens R, Ausma J. 2009. Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation- A 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 29:315-328.
24. Shioiri T, Yahagi K, Nakayama S, Asahara T, Yuki N, Kawakami K, Yamaoka Y, Sakai Y, Nomoto K, Totani M. 2006. The effects of a symbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: A randomized placebo-controlled cross-over study. Biosci Microflora 25:137-146.
25. Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. 2009. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 58: 357-365.
26. Yang YX, He M, Hu G,Wei J, Pages P, Yang XH, Bourdu-Naturel S. 2008. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 14:6237-6243